Is HeartSciences Inc. (HSCS) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research · 2 days ago
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude MiningGlobeNewsWire · 3 days ago
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM DeviceGlobeNewsWire · Oct 6, 2026
Fortitude Appoints Kimberly Pittman as Chief Legal OfficerBusiness Wire · Sep 29, 2026
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business UpdateGlobeNewsWire · Sep 15, 2026
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research · Sep 14, 2026HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination.
| Date | Est. | Actual | |
|---|---|---|---|
| Sep 16, 2026 | -$0.72 | -$0.86 | Miss |
| Jul 23, 2026 | -$0.66 | -$0.88 | Miss |
| Mar 16, 2026 | -$0.84 | -$0.63 | Beat |
| Dec 15, 2025 | -$0.90 | -$0.85 | Beat |
| Sep 11, 2025 | -$2.41 | -$1.58 | Beat |
| Jul 24, 2025 | -$2.51 | -$1.88 | Beat |